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(SEE INSTRUCTIONS) 
Publications 
"Reactivity of Bovine Blood Coagulation Factor IXa, Factor Xa, and Factor XIa 
toward Fluorogenic Peptides Containing the Activation Site Sequences of Bovine Factor IX 
and Factor X," Castillo, M.J., Kurachi, K., Nishino, N., Ohkubo, I., and Powers, 
J.C.(1983) Biochemistry 22 , 1021-1029. 
Publications Submitted 
"Benzyl-4-guanidinothiobenzoate Hydrochloride: A New Active-Site Titrant for 
Trypsin-like Enzymes," Cook, R.R., and Powers, J.C.(1983) Biochem. J. , submitted. 
"Mammalian Trypsin-like Enzymes. Comparative Reactivities of Airman Skin Tryptase, 
Human Lung Tryptase and Bovine Trypsin with Peptide 4-Nitroanilide and Thioester 
Substrates," Tanaka, T., McRae, B.J., Cho, K, Cook, R., Fraki, J.E., Johnson, D.A., and 
Powers, J.C.(1983) J. Biol. Chem. , submitted. 
"Active Site MNTOWTOT Blood Coagulation Serine Protease. Studies of the S3 
Subsite of Factor IXa, Factor Xa, Factor XIa, Factor XIIa, Thrombin and Activated 
Protein C Using Tripeptide 4-Nitroanilide Substrates and the S2 and S1' Subsite of 
Protein C and Factor XIIa Using Amino Acid and Dipeptide Thioesters. Comparison of the 
Relative Reactivities of Human and Bovine Factor XIIa and Activated Protein C," Cho, K., 
Tanaka, T., Cook, R.R., Kisiel, W., Fujikawa, K., Kurachi, K., and Powers, J.C.(1983) 
Biochemistry , submitted. 
Progress Report 
Scientific Goals. The goal of this research is to understand the nature of the 
active sites of plasma serine proteases and other related trypsin-like enzymes. These 
proteins are the basis of important physiological processes such as blood clotting, 
fibrinolysis and the immune defense mechanism involving the complement system. The 
tools for the investigation will be synthetic peptides. Synthetic peptides 
corresponding to sites which are cleaved by various plasma proteases will be prepared. 
The binding of these peptides to plasma proteases and their rates of hydrolysis will be 
determined. In addition we plan to design and synthesize small peptide thioesters which 
are more reactive toward serine proteases than simple peptides. These will be utilized 
to develop more sensitive and specific assays for individual enzymes. 
Progress. We have synthesized peptides containing the activation sequences of 
bovine factors IX and X and studied their reaction with bovine factors XIa and IXa. The 
substrates contain a fluorophore and a quenching group which are separated upon 
enzymatic hydrolysis with a resultant increase in fluorescence which was utilized to 
measure hydrolysis rates. Factor XIa cleaved all the peptides bearing factor IX 
activation site sequences. The kinetic behavior of factor XIa toward the synthetic 
peptide substrates indicates that it has a minimal extended substrate recognition site 
at least five residues long and has favorable interactions over seven subsites. The 
hexapeptide Abz-Glu-Phe-Ser-Arg-Val-Val-Nba was the most specific factor XIa substrate 
and was not hydrolyzed by factors IXa or Xa or thrombin. Factor IXa failed to hydrolyze 
any of the synthetic peptides bearing the activation site sequence of factor X. This 
enzyme slowly cleaved four peptide substrates with factor IX activation site sequences. 
Thrombin failed to cleave any of the peptides examined. Both factor IXa and XIa cleaved 
the peptide substrates at similar rates to their natural substrates under comparable 
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conditions. However the rates were substantially lower than optimum activation rates 
observed in the presence of calcium, phospholipids, and protein cofactors. This work 
has been published. 
Benzyl-4-guanidinothiobenzoate hydrochloride has been synthesized and demostrated 
to be useful for active-site titration of trypsin, thrombin, human lupg tryptase, 
activated protein C, factor XIIa and factor Xa. The titration is based upon rapid 
formation of a stable acyl enzyme with stoichionetric release of benzyl thiol. The 
thiol production is quanititated by including 4,4'-dithiodipyridine in the reaction 
mixture and measuring the increase in absorbance at 324 nm. Advantages of this reagent 
as a titrant include: flexibility in detection of the released thiol, selectivity 
between trypsin and chymotrypsin-like enzymes, relative stablity of the reagent under 
titration conditions, and high sensitivity. The reagent should prove useful as an 
alternate to 4-nitropheny1-4-guanidinobenzoate hydrochloride for the determination of 
active site concentrations of trypsin-like enzymes. 
The subsite specificity of human lung and skin tryptase (trypsin-like enzyme) has 
been studied at pH 7.5 using 17 amino acid and dipeptide thioester substrates and 14 
tripeptide 4-nitroanilide substrates. The reactivity and specificity of the human 
tryptases were compared with bovine trypsin and other trypsin-like enzymes. Neither 
tryptase was similar to either kallikrein or factor XIIa(Hagenan Factor). The skin 
enzyme was the most reactive as measured by the specificity constant. The best 
s4state was Z-Lys-Arg-SBu-i which had a k ,./K, value of 59,000,000 
M i s'. Both enzymes have extended substraEVbiHding sites and proline residues 
at P.4 substantially decrease k c , t /Km . Both enzymes preferred the tripeptide 
4-nitroanilides with a 1) 9 Gly rnidue over Phe, and both favored the P 1 
substrate Z-Lys-Gly-Arg-NA over similar substrates containing 6 other ► representative 
amino acid residues at P 3. The lung enzyme was inhibited over three times faster by 
p-amidinophenylmethane sulfonyl fluoride. The preference of the skin trypstase for 
substrates with two terminal basic residues indicates that this enzyme could process 
prohonnones and proproteins which contain this structural feature at the cleavage site. 
The substrates should be useful for the further characterization of the physiologic 
function of tryptases. 
A series of fourteen tripeptide 4-nitroanilide substrates of the type 
Z-AA-Gly-Arg-NA and Z-AA-Phe-Arg-NA where AA = Ala, Asn, Glu, Lys, Phe, Pro, or Ser were 
used to map the S subsite of blood coagulation serine proteases. The enzymes 
studied include thrombin, factor IXa, factor Xa, factor XIa, human factor XIIa, and 
bovine and human activated protein C. Kinetic constants for the enzymatic hydrolysis of 
the substrates by each enzyme were determined and used to compare the relative 
reactivities of the individual enzymes. Human factor XIIa showed the highest reactivity 
of all the coagulation proteases studied and was also very substrate specific. The best 
substrate was Z-Lys-Phe-Arg-NA. Bovine activated protein C (best substrate = 
Z-Ser-Phe-Arg-NA), factor Xa (best substrate = Z-Glu-Gly-Arg-NA) and thrombin (best 
substrate = Z-Lys-Gly-Arg-NA) were the group of enzymes that showed next highest 
reactivity toward the substrates. Bovine protein C and factor Xa displayed relatively 
little substrate specificity. Thrombin, likewise, demonstrated relatively little 
specificity but strongly disliked Z-Pro-Phe-Arg-NA which was not hydrolyzed at all 
Human activated protein C ( best substrate = Z-Ser-Phe-NA) and factor XIa (best 
substrate Z-Glu-Gly-Arg-NA) are moderately reactive enzymes. Human activated protein C 
is an extremely specific enzyme. Factor XIa, although very slow, hydrolyzed ten of the 
fourteen substrates. Human factor XIIa (best substrate = Z-Phe-Arg-SBu-i) and both 
bovine (best substrate = Z-Arg-SBz1) and human activated protein C (Z-Phe-Arg-SBu-i) 
were studied with a set of amino acid and dipeptide thioester substrates. The best 
thioester substrates were 10-359 fold better substrates than the best 4-nitroanilide 
substrates. Comparison of bovine and human factor XIIa, and bovine and human activated 
protein C showed substantial differences both in reactivity and in subsite preferences. 
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There were also significant similarities. These substrates should be useful for the 
future development of sensitive and specific assays for coagulation enzymes. 
Specific Objectives for Next Year. One objective for the comirip year will be to 
synthesize peptides contaiTing—IFE structural features of Gla residue's, Possible 
structures would include (HO 9C) 9CHCH 9CHCO-Spacer-peptide. Our purpose 
is to design peptides which toad bihd to phospholipid vesicles in the same manner as 
the natural substrates for factory IXa and Xa. Such substrates might be significantly 
more reactive and specific than the ones we have prepared to date. One of our major 
overall goals for the future is to increase the specificity of various substrates. 
We also intend to increase the sensitivity of some of our thioester substrates. We 
plan to incorporate a fluorophor and a quenching group in a substrate with a thioester 
bond. As the substrate is cleaved the fluorescence will increase and the activity of 
the enzyme can be followed kinetically. Due to the high reactivity of the thioester 
bond and high sensitivity of fluorescence detection, we hope to increase the sensitivity 
of our assays by several fold. 
Another objective will be to investigate the reaction of thioesters with zymogens. 
We have synthesized Boc-Ala-Ala-AA-SBzl where AA is 15 different amino acid residues. 
We plan to study these substrates with zymogens such as trypsinogen, chymotrypsinogen, 
factor X and prothrombin. If these studies are successful, we may try to do some 
subsite mapping of the zymogens. These studies could lead to direct assays for 
coagulaltion factors without the need of prior proteolytic activation. 
Finally, we are doing pattern recognition studies with the blood coagulation 
enzymes. We have now measured kinetic constants for the hydrolysis of 30 different 
substrates by over 14 trypsin-like enzymes. We are now trying to, relate the various 
enzymes by their reactivity toward the various substrates. 
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